Evidence map›Paper›PMID 40883809›Full record

ArticleJournal of cheminformatics2025

Biosynfoni: a biosynthesis-informed and interpretable lightweight molecular fingerprint.

Lucina-May Nollen, David Meijer, Maria Sorokina, Justin J J van der Hooft

Abstract read
In one paragraph

Article in Journal of cheminformatics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Lucina-May NollenBioinformatics Group, Wageningen University & Research, Droevendaalsesteeg 4, 6708 PB, Wageningen, the Netherlands.
David MeijerBioinformatics Group, Wageningen University & Research, Droevendaalsesteeg 4, 6708 PB, Wageningen, the Netherlands. david.meijer@wur.nl.
Maria SorokinaDS&AI, Bayer Pharmaceuticals, Mullerstrasse, 178, 13353, Berlin, Germany.
Justin J J van der HooftBioinformatics Group, Wageningen University & Research, Droevendaalsesteeg 4, 6708 PB, Wageningen, the Netherlands. justin.vanderhooft@wur.nl.

Funding

European Research Council 948770
6 · The paper itself

Abstract

Natural products provide a rich source of bioactive molecules for a variety of applications. Molecular fingerprints are the tool of choice for systematic large-scale studies of their structures. However, current molecular fingerprints insufficiently represent characteristic features of natural products inherently, decreasing the interpretability of natural product-specific predictions. Here, we show that a natural product-specific molecular fingerprint based on a relatively small set of selected biosynthetic building blocks provides more interpretable predictions of biosynthetic distance and natural product classification. Our fingerprint Biosynfoni outperforms MACCS, Morgan, and Daylight-like fingerprints in biosynthetic distance estimation, using 39 substructure keys. Moreover, Biosynfoni's design, compactness, and concrete substructure definition allow easy visualisation of the detected substructures and their respective biosynthetic pathway origins. Through Biosynfoni, users can gain more insights from predictions and better examine the importance of features within machine learning models. Our results show that a short fingerprint consisting of biologically significant building blocks performs on par with top-performing molecular fingerprints for natural product classification while improving prediction explainability.

Indexed as

BiosynthesisBiosynthetic building blocksCheminformaticsClassificationMetabolic modularityMetabolomicsMolecular fingerprintNatural products

Identifiers

PMID40883809
PMCPMC12395878

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.